» Articles » PMID: 30302065

Radiofrequency Ablation for the Treatment of Barrett Esophagus With Low-Grade Dysplasia

Overview
Specialty Gastroenterology
Date 2018 Oct 11
PMID 30302065
Authors
Affiliations
Soon will be listed here.
References
1.
Qumseya B, Wani S, Desai M, Qumseya A, Bain P, Sharma P . Adverse Events After Radiofrequency Ablation in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2016; 14(8):1086-1095.e6. DOI: 10.1016/j.cgh.2016.04.001. View

2.
Shaheen N, Sharma P, Overholt B, Wolfsen H, Sampliner R, Wang K . Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360(22):2277-88. DOI: 10.1056/NEJMoa0808145. View

3.
Desai M, Saligram S, Gupta N, Vennalaganti P, Bansal A, Choudhary A . Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest Endosc. 2016; 85(3):482-495.e4. DOI: 10.1016/j.gie.2016.09.022. View

4.
Cotton C, Wolf W, Overholt B, Li N, Lightdale C, Wolfsen H . Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial. Gastroenterology. 2017; 153(3):681-688.e2. PMC: 5581683. DOI: 10.1053/j.gastro.2017.05.044. View

5.
Phoa K, van Vilsteren F, Weusten B, Bisschops R, Schoon E, Ragunath K . Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014; 311(12):1209-17. DOI: 10.1001/jama.2014.2511. View